SCHEMBL20127702

SCHEMBL20127702

c1ccc2cc(-c3ccc4cc(-c5c6ccccc6c(-c6cc7c8ccccc8oc7c7c6oc6ccccc67)c6ccccc56)ccc4c3)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.37
ALOX5 P09917 3/20 0.36
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 1/20 0.36
CYP1A2 P05177 2/20 0.36
NPC1 O15118 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
AHR P35869 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
CASP7 P55210 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALPI P09923 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122250 0.99 GPR84 (0.38) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL10122231 0.96 ALOX5 (0.37) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL10122257 0.96 GPR84 (0.36) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL17944111 0.95 PGR (0.38) GPR84ALOX5CYP1B1NPC1RAB9A
SCHEMBL10122326 0.94 GPR84 (0.40) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL19081475 0.93 KDM4E (0.38) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL10122323 0.93 GPR84 (0.36) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL10122258 0.92 GPR84 (0.37) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL10122319 0.91 ALOX5 (0.40) GPR84ALOX5CYP1A1CYP1B1CYP1A2
SCHEMBL20127696 0.91 GPR84 (0.39) GPR84ALOX5CYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 GPR84 2389/4885ALOX5 4115/4885CYP1A1 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.